NCT03799380View on ClinicalTrials.gov

DRIHNC - Dehydration Reduction in Head & Neck Cancer

NACompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

November 5, 2019

Primary Completion Date

May 5, 2021

Study Completion Date

May 5, 2021

Conditions
DehydrationHead & Neck CancerEsophageal Cancer
Interventions
DIETARY_SUPPLEMENT

Gatorade G2

Gatorade (G2), 20 oz. bottle, daily through the entire course of radiation therapy (approximately 5-7 weeks)

DIETARY_SUPPLEMENT

Standard of care nutritional support

Standard of care nutritional support

Trial Locations (1)

44106

Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland

All Listed Sponsors
lead

Case Comprehensive Cancer Center

OTHER

NCT03799380 - DRIHNC - Dehydration Reduction in Head & Neck Cancer | Biotech Hunter | Biotech Hunter